Recently published scientific studies include research into whether Covid-19 immunity might not be possible.

Heartburn sufferers who do not feel better with standard treatment, but who have no detectable reflux, tend to have greater distress and worse quality of life, according to a new study.

Ironwood Pharmaceuticals touted its Phase IIb drug candidate IW-3718 in adult patients with uncontrolled gastroesophageal reflux disease (GERD), but investors seem wary as share prices were down more than 7 percent.

People taking common heartburn medications known as proton pump inhibitors (PPIs) are at increased risk of new and severe kidney disease, according to a U.S. study. Among hundreds of thousands of patients in Department of Veterans Affairs (VA) databases, new users of PPIs without kidney disease were 30 percent more likely to develop chronic kidney […]